Brain Glutathione Levels – A Novel Biomarker for Mild Cognitive Impairment and Alzheimer’s Disease

  title={Brain Glutathione Levels – A Novel Biomarker for Mild Cognitive Impairment and Alzheimer’s Disease},
  author={Pravat Kumar Mandal and Sumiti Saharan and Manjari Tripathi and Geetanjali Murari},
  journal={Biological Psychiatry},

Figures and Tables from this paper

Altered central and blood glutathione in Alzheimer’s disease and mild cognitive impairment: a meta-analysis

Blood intracellular GSH decrease is seen in MCI, while both intra- and extracellular decreases were seen in AD, and potential bias and heterogeneity suggest the need for measurement standardization and additional studies to explore sources of heterogeneity.

Interplay Between Hippocampal Glutathione Depletion and pH Increment in Alzheimer's Disease.

A schematic model is proposed depicting the molecular events in AD pathogenesis and providing a possible link between OS, GSH depletion, and pH alterations in the hippocampus to potentiate the need for in vivo longitudinal studies to confirm the interlinked mechanism.

Hippocampal Glutathione Depletion and pH Increment in Alzheimer's Disease: An in vivo MRS Study.

Outcomes from this study provide further insights to metabolic alterations in terms of concurrent assessment of hippocampal GSH and pH levels in AD pathogenesis, aiding in early diagnosis of MCI and AD.

Hippocampal glutathione depletion with enhanced iron level in patients with mild cognitive impairment and Alzheimer’s disease compared with healthy elderly participants

It is concluded that tandem glutathione and iron provides novel avenue to investigate further research in Alzheimer’s disease.

Quantitation of in vivo brain glutathione conformers in cingulate cortex among age‐matched control, MCI, and AD patients using MEGA‐PRESS

It is concluded that only closed GSH conformer depletion in the ACC and PCC regions is critical and constitute a potential biomarker for AD.

Imaging Amnestic Mild Cognitive Impairment: Neuroinflammation, Beta-amyloid and Glutathione

The findings suggest that amyloid pathology is an early event, whereas neuroinflammation and alterations in glutathione may occur only after conversion to AD.

Relationships among Cortical Glutathione Levels, Brain Amyloidosis, and Memory in Healthy Older Adults Investigated In Vivo with 1H-MRS and Pittsburgh Compound-B PET

An association between cortical glutathione levels and brain amyloidosis in healthy older adults is found, suggesting a potential role for 1H-MR spectroscopy measures of glutathion as a noninvasive biomarker of early Alzheimer disease pathogenesis.

Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology

Iron was strongly associated with the rate of cognitive decline in subjects who were diagnosed with clinical AD during life and had a diagnosis of AD confirmed post-mortem by standardized criteria, and might act to propel cognitive deterioration upon the underlying proteinopathy of AD.

Iron and Alzheimer’s Disease: From Pathology to Imaging

The existing evidence of pathological iron accumulation in the human AD brain is presented, as well as the imaging tools and peripheral measures available to characterize iron accumulation and dysregulation in AD, which may help in developing iron-based biomarkers or therapeutic targets for the disease.

Meta-Analysis of Neurochemical Changes Estimated via Magnetic Resonance Spectroscopy in Mild Cognitive Impairment and Alzheimer's Disease

Meta-analysis showed that during the progression from MCI to AD, N-acetyl aspartate (NAA) decreased continuously in the posterior cingulate (PC) and myo-inositol (mI) was associated with the cognitive decline and might be used as potentially biomarkers to predict the possible progression to Alzheimer's disease.



Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment

It is shown that some peripheral markers of oxidative stress appear in MCI with a similar pattern to that observed in AD, which suggests that oxidative stress might represent a signal of the AD pathology.

The emerging role of glutathione in Alzheimer's disease.

The present manuscript integrates findings from various studies to elucidate the possible molecular mechanisms through which disruptions in GSH homeostasis may contribute to AD pathology.

Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T

The lower GSH levels in patients with secondary progressive multiple sclerosis indicate the presence of oxidative stress in SPMS, which could be at least partially responsible for ongoing functional decline in these patients.

Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease

Gender differences in glutathione metabolism in Alzheimer's disease

It was shown for the first time that GSH metabolism was regulated differently in male and female AD patients, suggesting that a decreased de novo GSH synthetic capacity is responsible for the decline in GSH content in AD.

Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease

Evidence of increased oxidative damage in subjects with mild cognitive impairment

Oxidative damage occurs in the brain of subjects with mild cognitive impairment, suggesting that oxidative damage may be one of the earliest events in the onset and progression of Alzheimer disease.

Elevated Oxidative Stress and Decreased Antioxidant Function in the Human Hippocampus and Frontal Cortex with Increasing Age: Implications for Neurodegeneration in Alzheimer’s Disease

It is suggested that the regions HC and FC are subjected to widespread oxidative stress, loss of antioxidant function and enhanced GFAP expression during aging which might make them more susceptible to deranged physiology and selective neuronal degeneration.